"Signature Disease" Status Doesn't Change Analysis

Law360, New York (February 8, 2008, 12:00 AM EST) -- The federal court charged with overseeing the Fosamax multidistrict products liability litigation recently declined plaintiffs' request to certify three state-specific classes seeking recovery for medical monitoring.

The putative representative claimants had failed to satisfy the requirements for class certification under Rule 23, according to Judge John F. Keenan of the U.S. District Court for the Southern District of New York, because the proposed class definitions were irreparably overbroad and because too many individual questions of fact particular to each class member's claim rendered class treatment an...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.